» Authors » Mamoru Morikawa

Mamoru Morikawa

Explore the profile of Mamoru Morikawa including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 151
Citations 792
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Hayakawa M, Seki Y, Ikezoe T, Yamakawa K, Okamoto K, Kushimoto S, et al.
Int J Hematol . 2025 Jan; PMID: 39890756
Disseminated intravascular coagulation (DIC) is a complex condition with diverse etiologies. While its association with sepsis has been widely studied, less focus has been given to DIC arising from other...
2.
Morikawa M, Matsunaga S, Makino S, Takeda Y, Hyodo H, Nii M, et al.
J Obstet Gynaecol Res . 2025 Jan; 51(2):e16220. PMID: 39887536
Aim: The purpose of this study is to clarify the frequencies of fresh frozen plasma (FFP) ± fibrinogen concentrate administration (fibrinogen concentrate [FC] therapy) and antithrombin (AT) concentrate administration (AT...
3.
Morikawa M, Takeda Y, Matsunaga S, Makino S, Eto E, Serizawa M, et al.
Sci Rep . 2024 Jul; 14(1):17677. PMID: 39085285
Since July 2022, obstetrical disseminated intravascular coagulation (DIC) in Japan has been diagnosed based on the new criteria (tentative version), which assesses the main underlying disease, fibrinogen level, and fibrin/fibrinogen...
4.
Nii M, Oda T, Morikawa M, Nakabayashi Y, Adachi T, Kobayashi T, et al.
Sci Rep . 2024 Mar; 14(1):6711. PMID: 38509152
Fibrinogen concentrate (FC) for acquired hypofibrinogenemia associated with critical obstetrical hemorrhage (COH) was covered by public medical insurance in September 2021 in Japan. We aimed to investigate changes in the...
5.
Morikawa M, Kamiya A, Yoshida A, Nishibata S, Okada H
Int J Hematol . 2024 Jan; 119(3):265-274. PMID: 38253960
The new Japanese diagnostic criteria for obstetrical disseminated intravascular coagulation (DIC) (tentative version) were released in June 2022. We aimed to demonstrate the differences in characteristics between women with DIC...
6.
Morikawa Y, Watanabe Y, Yamauchi M, Yamamoto M, Morikawa M, Ishibiki K, et al.
PLoS One . 2022 Dec; 17(12):e0278638. PMID: 36454971
This study aimed to clarify the educational significance and issues associated with administering the objective structured clinical examination (OSCE) twice to midwifery students, i.e., before and after clinical training. In...
7.
Morikawa M, Sugiyama T, Hiramatsu Y, Sagawa N
Endocr J . 2022 Jul; 69(11):1313-1322. PMID: 35781264
This study aimed to investigate the relationship between gestational diabetes mellitus (GDM) screening methods and GDM incidences. In 2018, a national questionnaire was administered at 231 institutions (56.6%) of all...
8.
Yokoe T, Kita M, Suzuki K, Butsuhara Y, Yoshida A, Morikawa M, et al.
Ann Med Surg (Lond) . 2022 May; 77:103686. PMID: 35638002
Introduction: and importance: Postpartum retroperitoneal hematomas are a potential complication of childbirth. The management of secondary infections of such hematomas has not been fully elucidated. We present a typical case...
9.
Morikawa M, Ieko M, Nakagawa-Akabane K, Umazume T, Chiba K, Kawaguchi S, et al.
Int J Hematol . 2022 Mar; 116(1):60-70. PMID: 35316497
Background: The best thromboprophylaxis for pregnant women with congenital antithrombin deficiency (CAD) is controversial. Objective: To clarify the effectiveness of a protocol for venous thromboembolism (VTE) prevention in pregnant women...
10.
Morikawa M, Adachi T, Itakura A, Nii M, Nakabayashi Y, Kobayashi T
J Obstet Gynaecol Res . 2021 Dec; 48(3):663-672. PMID: 34957638
Aim: To clarify the relation between institutions capacity to manage venous thromboembolism (VTE) and its incidence in pregnant women throughout Japan. Methods: Among the 2299 institutions that received the surveillance...